HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Bruno Schjöth Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Carteaux, J.-P. Articles by Villemot, J.-P. Search for Related Content PubMed PubMed Citation Articles by Carteaux, J.-P. Articles by Villemot, J.-P.

Eur J Cardiothorac Surg 1999;15:346-352
© 1999 Elsevier Science NL

Acute pulmonary hypertension after cardiopulmonary bypass in pig: the role of endogenous endothelin

^a Laboratoire de Chirurgie Experimentale, Faculte de Medecine de Nancy, Nancy, France
^b Pharma Division, Preclinical Research, F. Hoffmann-la Roche Ltd, CH-4002 Basel, Switzerland

Received 8 June 1998; received in revised form 21 December 1998; accepted 8 January 1999.

Corresponding author. Service de Chirurgie Cardiaque et de Transplantation Cardiothoracique, C.H.U. de Brabois, Rue du Morvan, 54511 Vandoeuvre les Nancy, France. Tel.: +33-383-153-034; fax: +33-383-440-844; e-mail: jp.carteaux@chu-nancy.fr

Background: Acute pulmonary hypertension occurring after cardiopulmonary bypass can be a cause of post-operative morbidity and mortality. The purpose of this study was to investigate whether bosentan, a non-peptidic mixed endothelin antagonist affected the pulmonary hypertension induced by experimental cardiopulmonary bypass. Methods: Pigs were anesthetized and instrumented to determine hemodynamic measurements. Pigs were randomized to receive either 3 mg/kg bolus+7 mg/kg per h bosentan(n=8) or saline (n=7). All pigs underwent 90 min of cardiopulmonary bypass and were further observed for a 120-min period. Results: In the control group, cardiopulmonary bypass induced a dramatic pulmonary hypertension (+78±13%, P<0.005) and accompanied an increase of pulmonary vascular resistance (+228±50%, P<0.005), whereas, in the treated group, bosentan completely prevented these deleterious effects of cardiopulmonary bypass with only a moderate decrease of systemic vascular resistance (-19±14.6%, P<0.05). Conclusions: The present findings support the hypothesis that endogenous endothelin is a mediator of acute pulmonary hypertension occurring after cardiopulmonary bypass. Bosentan, a mixed endothelin antagonist completely prevented pulmonary hypertension after cardiopulmonary bypass and may, therefore, have therapeutic applications in the management of patients following cardiac surgery.

Key Words: Acute pulmonary arterial hypertension • Cardiopulmonary bypass • Endothelin • Bosentan • Pig

This article has been cited by other articles:

				A. Y. Denault, Y. Lamarche, P. Couture, F. Haddad, J. Lambert, J.-C. Tardif, and L. P. Perrault Inhaled milrinone: a new alternative in cardiac surgery? Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2006; 10(4): 346 - 360. [Abstract] [PDF]

				C. Joffs, C. A. Walker, J. W. Hendrick, D. J. Fary, D. K. Almany, J. N. Davis, A. T. Goldberg, F. A. Crawford Jr, and F. G. Spinale Endothelin receptor subtype A blockade selectively reduces pulmonary pressure after cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., August 1, 2001; 122(2): 365 - 370. [Abstract] [Full Text] [PDF]

				C. A. Walker, S. C. Baicu, A. T. Goldberg, C. E. Widener, D. J. Fary, D. K. Almany, A. Ergul, F. A. Crawford Jr, and F. G. Spinale Temporal endothelin dynamics of the myocardial interstitium and systemic circulation in cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., November 1, 2000; 120(5): 864 - 871. [Abstract] [Full Text] [PDF]